Comparison of Efficacy and Safety Between Imidafenacin and Fesoterodine in Patients With Overactive Bladder

NCT01578304 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

207

Enrollment

INDUSTRY

Sponsor class

Conditions

Overactive Bladder

Interventions

DRUG: Imidafenacin
DRUG: Fesoterodine

Sponsor

LG Life Sciences

Collaborators

[object Object]